Clinical trials: Low Back Pain (LBP)

Moderate to Severe Acute Lower Back Pain

Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain

• Completed
• Age: 18 to 75 years
• Phase 2
• Results posted

This is a Phase 2, randomized, double-blind, placebo-controlled, parallel group, multicenter study to evaluate the safety and efficacy of SP-103 in subjects with moderate to severe acute lower back pain.

Trial name

NCT05096494

Testing

SP-103

Where

10 sites in United States

Volunteers

76 people

Sponsor

Scilex Pharmaceuticals, Inc.